Cel-Sci, partner to advance HIV/HPV drug – Washington Business Journal (blog)

Cel-Sci, partner to advance HIV/HPV drug
Washington Business Journal (blog)
Vienna-based Cel-Sci, already running late-stage clinical trials for its experimental head and neck cancer drug Multikine, will advance studies of the same drug in treating women infected with both HIV and HPV who have cervical dysplasia. Ergomed
CEL-SCI, Ergomed To Co-Develop Head And Neck Cancer Candidate As News-Medical.net

all 4 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *